These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29057460)

  • 1. Psoriasis and small intestine bacterial overgrowth.
    Drago F; Ciccarese G; Indemini E; Savarino V; Parodi A
    Int J Dermatol; 2018 Jan; 57(1):112-113. PubMed ID: 29057460
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
    Furnari M; Parodi A; Gemignani L; Giannini EG; Marenco S; Savarino E; Assandri L; Fazio V; Bonfanti D; Inferrera S; Savarino V
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1000-6. PubMed ID: 20937045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal bacterial overgrowth.
    Rana SV; Bhardwaj SB
    Scand J Gastroenterol; 2008; 43(9):1030-7. PubMed ID: 18609165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial overgrowth syndrome].
    Stein JM; Schneider AR
    Z Gastroenterol; 2007 Jul; 45(7):620-8. PubMed ID: 17620228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of bile acid breath test in the diagnosis of bacterial overgrowth in the small intestine with and without the stagnant (blind) loop syndrome.
    Farivar S; Fromm H; Schindler D; Schmidt FW
    Dig Dis Sci; 1979 Jan; 24(1):33-40. PubMed ID: 428288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer.
    Bustillo I; Larson H; Saif MW
    JOP; 2009 Sep; 10(5):576-8. PubMed ID: 19734643
    [No Abstract]   [Full Text] [Related]  

  • 7. Small intestinal bacterial overgrowth in adult patients with type 1 diabetes.
    Bulanda M; Gosiewski T; Brzychczy-Włoch M
    Pol Arch Med Wewn; 2016 Sep; 126(9):623-624. PubMed ID: 27698331
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up.
    Drago F; De Col E; Agnoletti AF; Schiavetti I; Savarino V; Rebora A; Paolino S; Cozzani E; Parodi A
    J Am Acad Dermatol; 2016 Sep; 75(3):e113-e115. PubMed ID: 27543234
    [No Abstract]   [Full Text] [Related]  

  • 9. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Aziz I; Törnblom H; Simrén M
    Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable.
    Tarnopolsky MA; Pearce E; Matteliano A; James C; Armstrong D
    Muscle Nerve; 2010 Dec; 42(6):853-5. PubMed ID: 21104859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
    Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
    J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB; Geng B; Brandes SB
    Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy].
    Mechetina TA; Il'chenko AA; Lychkova AE
    Eksp Klin Gastroenterol; 2011; (3):93-100. PubMed ID: 21695956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing nature of small intestine bacterial overgrowth.
    Toskes PP
    Curr Gastroenterol Rep; 1999 Aug; 1(4):267-8. PubMed ID: 10980960
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation.
    Rosania R; Giorgio F; Principi M; Amoruso A; Monno R; Di Leo A; Ierardi E
    Curr Clin Pharmacol; 2013 May; 8(2):169-72. PubMed ID: 23244247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis.
    Sakamaki A; Yokoyama K; Yamazaki F; Kamimura H; Kamimura K; Takamura M; Yokoyama J; Terai S
    Intern Med; 2020 Aug; 59(15):1849-1853. PubMed ID: 32321898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
    Gabrielli M; D'Angelo G; Di Rienzo T; Scarpellini E; Ojetti V
    Eur Rev Med Pharmacol Sci; 2013; 17 Suppl 2():30-5. PubMed ID: 24443065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics].
    Lykova EA; Bondarenko VM; Parfenov AI; Matsulevich TV
    Eksp Klin Gastroenterol; 2005; (6):51-7, 113. PubMed ID: 17378388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial.
    Kim BT; Kim KM; Kim KN
    Nutrients; 2020 May; 12(5):. PubMed ID: 32422942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
    Cuoco L; Salvagnini M
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.